A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA1c) on exenatide treatment: Letters: Original Observations

Diabetic Medicine

Volumn 26, Issue 2, 2009, Pages 190-

  Brooks, A M S ^a   Lissett, C A ^a  

^a TORBAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN;

ADULT; CASE REPORT; DETERIORATION; DIABETIC RETINOPATHY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT RESPONSE;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; PEPTIDES; VENOMS;

EID: 60049092893     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02650.x     Document Type: Letter

References (6)

1. Nielsen LL, Baron AD. Pharmacology of exenatide (synthetic exendin-4) for the treatment of Type 2 diabetes. Curr Opin Investig Drugs 2003 4 : 401 405.
2. Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with Type 2 diabetes treated for at least 3 years. Curr Med Res Opin 2008 24 : 275 286.
3. The Diabetes Control and Complications Trial, Epidemiology of Diabetes Intervention and Complications Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998 116 : 874 886.
4. Arun CS, Pandit R, Taylor R. Long-term progression of retinopathy after initiation of insulin therapy in Type 2 diabetes: an observational study. Diabetologia 2004 47 : 1380 1384.
5. Grunwald JE, Riva CE, Martin DB, Quint AR, Epstien PA. Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. Ophthalmology 1987 94 : 1614 1620.
6. Chantelau E. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br J Ophthalmol 1998 82 : 725 730.